nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Rifampicin—leprosy	0.126	0.131	CbGbCtD
Loratadine—CYP2C19—Thalidomide—leprosy	0.109	0.113	CbGbCtD
Loratadine—CYP2C19—Rifampicin—leprosy	0.105	0.11	CbGbCtD
Loratadine—CYP2C8—Dapsone—leprosy	0.104	0.108	CbGbCtD
Loratadine—CYP2C9—Thalidomide—leprosy	0.0905	0.0943	CbGbCtD
Loratadine—CYP2C9—Rifampicin—leprosy	0.0877	0.0914	CbGbCtD
Loratadine—CYP2C19—Dapsone—leprosy	0.0871	0.0907	CbGbCtD
Loratadine—ABCB1—Rifampicin—leprosy	0.0851	0.0887	CbGbCtD
Loratadine—CYP2C9—Dapsone—leprosy	0.0724	0.0754	CbGbCtD
Loratadine—CYP3A4—Rifampicin—leprosy	0.051	0.0531	CbGbCtD
Loratadine—CYP3A4—Dapsone—leprosy	0.0421	0.0439	CbGbCtD
Loratadine—Viral infection—Thalidomide—leprosy	0.00144	0.0357	CcSEcCtD
Loratadine—Drug interaction—Thalidomide—leprosy	0.0014	0.0348	CcSEcCtD
Loratadine—Pharyngitis—Dapsone—leprosy	0.00126	0.0314	CcSEcCtD
Loratadine—Tinnitus—Dapsone—leprosy	0.00119	0.0295	CcSEcCtD
Loratadine—Hyperkinesia—Thalidomide—leprosy	0.00113	0.0282	CcSEcCtD
Loratadine—Increased appetite—Thalidomide—leprosy	0.001	0.0249	CcSEcCtD
Loratadine—Dermatitis bullous—Thalidomide—leprosy	0.000986	0.0245	CcSEcCtD
Loratadine—Cough—Dapsone—leprosy	0.000968	0.0241	CcSEcCtD
Loratadine—Lethargy—Thalidomide—leprosy	0.000962	0.0239	CcSEcCtD
Loratadine—Tachycardia—Dapsone—leprosy	0.000883	0.022	CcSEcCtD
Loratadine—Insomnia—Dapsone—leprosy	0.000819	0.0203	CcSEcCtD
Loratadine—Pollakiuria—Thalidomide—leprosy	0.000753	0.0187	CcSEcCtD
Loratadine—Gastrointestinal pain—Dapsone—leprosy	0.00074	0.0184	CcSEcCtD
Loratadine—Drowsiness—Thalidomide—leprosy	0.000726	0.0181	CcSEcCtD
Loratadine—Depression—Thalidomide—leprosy	0.000724	0.018	CcSEcCtD
Loratadine—Body temperature increased—Dapsone—leprosy	0.000715	0.0178	CcSEcCtD
Loratadine—Abdominal pain—Dapsone—leprosy	0.000715	0.0178	CcSEcCtD
Loratadine—Epistaxis—Thalidomide—leprosy	0.000685	0.017	CcSEcCtD
Loratadine—Pharyngitis—Thalidomide—leprosy	0.000647	0.0161	CcSEcCtD
Loratadine—Tinnitus—Thalidomide—leprosy	0.000608	0.0151	CcSEcCtD
Loratadine—Immune system disorder—Thalidomide—leprosy	0.000589	0.0146	CcSEcCtD
Loratadine—Arrhythmia—Thalidomide—leprosy	0.000583	0.0145	CcSEcCtD
Loratadine—Alopecia—Thalidomide—leprosy	0.000576	0.0143	CcSEcCtD
Loratadine—Vomiting—Dapsone—leprosy	0.000575	0.0143	CcSEcCtD
Loratadine—Headache—Dapsone—leprosy	0.000567	0.0141	CcSEcCtD
Loratadine—Tension—Thalidomide—leprosy	0.000557	0.0138	CcSEcCtD
Loratadine—Dysgeusia—Thalidomide—leprosy	0.000556	0.0138	CcSEcCtD
Loratadine—Nervousness—Thalidomide—leprosy	0.000551	0.0137	CcSEcCtD
Loratadine—Nausea—Dapsone—leprosy	0.000538	0.0134	CcSEcCtD
Loratadine—Ill-defined disorder—Thalidomide—leprosy	0.000527	0.0131	CcSEcCtD
Loratadine—Agitation—Thalidomide—leprosy	0.000522	0.013	CcSEcCtD
Loratadine—Angioedema—Thalidomide—leprosy	0.000519	0.0129	CcSEcCtD
Loratadine—Malaise—Thalidomide—leprosy	0.000512	0.0127	CcSEcCtD
Loratadine—Syncope—Thalidomide—leprosy	0.000509	0.0127	CcSEcCtD
Loratadine—Palpitations—Thalidomide—leprosy	0.000502	0.0125	CcSEcCtD
Loratadine—Loss of consciousness—Thalidomide—leprosy	0.000499	0.0124	CcSEcCtD
Loratadine—Cough—Thalidomide—leprosy	0.000495	0.0123	CcSEcCtD
Loratadine—Hypertension—Thalidomide—leprosy	0.00049	0.0122	CcSEcCtD
Loratadine—Myalgia—Thalidomide—leprosy	0.000483	0.012	CcSEcCtD
Loratadine—Chest pain—Thalidomide—leprosy	0.000483	0.012	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00048	0.0119	CcSEcCtD
Loratadine—Discomfort—Thalidomide—leprosy	0.000477	0.0119	CcSEcCtD
Loratadine—Dry mouth—Thalidomide—leprosy	0.000473	0.0117	CcSEcCtD
Loratadine—Shock—Thalidomide—leprosy	0.000456	0.0113	CcSEcCtD
Loratadine—Nervous system disorder—Thalidomide—leprosy	0.000454	0.0113	CcSEcCtD
Loratadine—Tachycardia—Thalidomide—leprosy	0.000452	0.0112	CcSEcCtD
Loratadine—Skin disorder—Thalidomide—leprosy	0.00045	0.0112	CcSEcCtD
Loratadine—Hypotension—Thalidomide—leprosy	0.000433	0.0108	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000422	0.0105	CcSEcCtD
Loratadine—Insomnia—Thalidomide—leprosy	0.000419	0.0104	CcSEcCtD
Loratadine—Paraesthesia—Thalidomide—leprosy	0.000416	0.0103	CcSEcCtD
Loratadine—Somnolence—Thalidomide—leprosy	0.000412	0.0102	CcSEcCtD
Loratadine—Dyspepsia—Thalidomide—leprosy	0.000408	0.0101	CcSEcCtD
Loratadine—Gastrointestinal disorder—Thalidomide—leprosy	0.0004	0.00994	CcSEcCtD
Loratadine—Fatigue—Thalidomide—leprosy	0.000399	0.00993	CcSEcCtD
Loratadine—Constipation—Thalidomide—leprosy	0.000396	0.00985	CcSEcCtD
Loratadine—Pain—Thalidomide—leprosy	0.000396	0.00985	CcSEcCtD
Loratadine—Feeling abnormal—Thalidomide—leprosy	0.000382	0.00949	CcSEcCtD
Loratadine—Gastrointestinal pain—Thalidomide—leprosy	0.000379	0.00942	CcSEcCtD
Loratadine—Abdominal pain—Thalidomide—leprosy	0.000366	0.0091	CcSEcCtD
Loratadine—Body temperature increased—Thalidomide—leprosy	0.000366	0.0091	CcSEcCtD
Loratadine—Asthenia—Thalidomide—leprosy	0.000332	0.00826	CcSEcCtD
Loratadine—Diarrhoea—Thalidomide—leprosy	0.000317	0.00788	CcSEcCtD
Loratadine—Dizziness—Thalidomide—leprosy	0.000306	0.00762	CcSEcCtD
Loratadine—Vomiting—Thalidomide—leprosy	0.000295	0.00732	CcSEcCtD
Loratadine—Rash—Thalidomide—leprosy	0.000292	0.00726	CcSEcCtD
Loratadine—Dermatitis—Thalidomide—leprosy	0.000292	0.00725	CcSEcCtD
Loratadine—Headache—Thalidomide—leprosy	0.00029	0.00721	CcSEcCtD
Loratadine—Nausea—Thalidomide—leprosy	0.000275	0.00684	CcSEcCtD
